Form 4: IGM Biosciences Officer Chris H Takimoto Sells Shares to Cover Tax Obligations

Chris H Takimoto, Chief Medical Officer of IGM Biosciences, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Chris H Takimoto, the Chief Medical Officer of IGM Biosciences, sold shares of the company's common stock on March 13 and 14, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On March 13, 2024, 2,889 shares were sold at a weighted average price of $9.8752, with prices ranging from $9.625 to $10.01.
• On March 14, 2024, 2,535 shares were sold at a weighted average price of $10.1705, with prices ranging from $9.80 to $10.43.
• Following these transactions, Takimoto directly owns 94,388 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock sales for tax purposes, indicating a neutral sentiment.

Industry Context

Sales of shares by company officers are a common occurrence, often related to compensation and tax obligations. The impact on the stock price is usually minimal unless the sales are unusually large or indicative of a change in the officer's confidence in the company.

Stakeholder Impact

• The stock sales may have a minor dilutive effect on existing shareholders, but the impact is likely to be minimal.

Key Dates